Inhibition Of IGF1R by IGF-1R/IR Inhibitor OSI906 as a Targeted Therapy for Glioblastoma: In Vitro & in Vivo Studies

被引：0
|
作者：
Fernandez, M. C. [1 ]
Martin, A. [1 ]
Clement, F. [1 ]
Venara, M. C. [1 ]
Garcia Lombardi, M. [2 ]
Bergada, I [1 ]
Gutierrez, M. [1 ]
Pennisi, P. A. [1 ]
机构：
[1] Hosp Ninos Dr R Gutierrez, CONICET, Ctr Invest Endocrinol Dr Cesar Bergada, CEDIE,FEI,Div Endocrinol, Buenos Aires, DF, Argentina
[2] Hosp Ninos Dr R Gutierrez, Serv Oncol, Buenos Aires, DF, Argentina
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2019年 / 92卷
关键词：
IGF1R; Pediatric glioma; OSI906;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP5
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Inhibition of IGF1R by IGF1R/IR inhibitor OSI906 as a targeted therapy for glioblastoma: in vitro & in vivo studies
    Celia Fernandez, Maria
    Martin, Ayelen
    Clement, Florencia
    Venara, Marcela
    Fernanda Castro, Julia
    Garcia Lombardi, Mercedes
    Bergada, Ignacio
    Pennisi, Patricia
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 62 - 63
  • [2] OSI-906: A DUAL IGF-1R/IR INHIBITOR FOR THE TREATMENT OF CANCER
    Buck, E.
    Gokhale, P.
    Lerner, L.
    Wild, R.
    Pachter, J.
    Epstein, D.
    Miglarese, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 9 - 10
  • [3] Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor
    Liu, Qing
    Lorena, Lerner
    Tao, Nianjun
    Huang, Lu
    Yang, John
    Krieger, Brian
    Buck, Elizabeth
    Wang, Ruojie
    Kannan, Karuppiah
    Chiu, M. Isabel
    Robinson, Murray O.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [4] Generation of in vivo tumor models driven by Insulin-Like Growth Factor 1 Receptor IGF1R and their use in the development of OSI-906, a selective IGF1R inhibitor
    Lerner, Lorena
    Liu, Qing
    Yang, John
    Tao, Nianjun
    Krieger, Brian
    Zarycki, Jodi
    Huang, Lu
    Growney, Joseph
    Buck, Elizabeth
    Wang, Ruojie
    Rosenfeld-Franklin, Maryland
    Kannnan, Karuppiah
    Kan, Julie
    Pachter, Jonathan
    Chiu, Maria Isabel
    Epstein, David
    Robinson, Murray
    CANCER RESEARCH, 2009, 69
  • [5] Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials
    Ji, Qun-Sheng
    Mulvihil, Mark J.
    Rosenfeld-Franklin, Maryland
    Buck, Elizabeth
    Cooke, Andrew
    Eyzaguirrel, Alexandra
    Mak, Gilda
    O'Connor, Matthew
    Pirritt, Caroline
    Yao, Yan
    Gibson, Neil W.
    Pachter, Jonathan A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3590S - 3590S
  • [6] Targeting the Insulin-like Growth Factor 1 (IGF1R) and Insulin (IR) Receptor with a Dual IGF1R/IR Inhibitor, OSI-906, to Potentiate mTOR Inhibitor Effects in Exeperimental Models of Hepatocellular Carcinoma (HOC)
    Pivonello, Claudia
    Negri, Mariarosaria
    De Martino, Maria Cristina
    Napolitano, Maria
    de Angelis, Cristina
    Izzo, Francesco
    Colao, Annamaria
    Hofland, Leo J.
    Pivonello, Rosario
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [7] A role for IGF-1R targeted therapy in SCLC?
    Gately, K.
    Collins, I.
    Forde, L.
    Al-Alao, A.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S12 - S12
  • [8] Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer
    Lerner, Lorena
    Liu, Qing
    Tao, Nianjun
    Yang, John
    Brown, Eric
    Koujak, Susan
    Krieger, Brian
    Huang, Lu
    Rosenfeld-Franklin, Maryland
    Miglarese, Mark
    Pachter, Jonathan
    Robinson, Murray O.
    Chiu, M. Isabel
    Epstein, David
    Buck, Elizabeth
    CANCER RESEARCH, 2011, 71
  • [9] Antitumor activity of antisense oligonucleotides targeted to IGF1R in vivo and in vitro
    Lin, L
    Wang, SQ
    Guan, W
    Yang, BH
    Hu, XD
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2002, 29 (02) : 247 - 251
  • [10] Epithelial mesenchymal transition (EMT) and IGF-2 expression as determinants of sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma
    Zhao, Hui
    Desai, Vidhi
    Wang, Jian
    Epstein, David
    Miglarese, Mark
    Rizzo, Elizabeth
    CANCER RESEARCH, 2011, 71
12345